Crispr Therapeutics Ag (CRSP) — DEFA14A Filings
All DEFA14A filings from Crispr Therapeutics Ag. Browse 1 DEFA14A reports with AI-powered summaries and risk analysis.
DEFA14A Filings (1)
-
CRISPR Therapeutics Files Proxy Materials
— Apr 9, 2024 Risk: low
CRISPR Therapeutics AG filed a Definitive Additional Materials (DEFA14A) on April 9, 2024. This filing is related to their proxy statement and indicates no fee
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX